|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.98 USD | -0.03% |
|
-.--% | -.--% |
| Feb. 11 | PetIQ, Inc. Announces CEO Changes | CI |
| 2024 | PetIQ Says It Has Been Acquired by Bansk Group for $1.5 Billion | MT |
| Capitalization | 919M 784M 731M 676M 1.26B 78.8B 1.41B 8.76B 3.32B 36.72B 3.45B 3.38B 135B | P/E ratio 2022 |
-5.58x | P/E ratio 2023 | 282x |
|---|---|---|---|---|---|
| Enterprise value | 1.27B 1.08B 1.01B 935M 1.74B 109B 1.95B 12.11B 4.6B 50.78B 4.77B 4.67B 186B | EV / Sales 2022 |
0.69x | EV / Sales 2023 | 0.84x |
| Free-Float |
91.62% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
| 1 day | -0.03% |
| 1 year | 19.8 |  | 31.06 |
| 3 years | 6.66 | | 31.06 |
| 5 years | 6.66 | | 46 |
| 10 years | 6.66 | | 46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Camillo Pane
CEO | Chief Executive Officer | 54 | 2025-02-16 |
Zvi Glasman
DFI | Director of Finance/CFO | 61 | 2022-01-02 |
Michael Smith
PSD | President | 47 | 2022-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Lambertus Becht
BRD | Director/Board Member | 69 | 2024-10-24 |
| Director/Board Member | - | 2024-10-24 | |
Timothy Stone
BRD | Director/Board Member | - | 2024-10-24 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.03% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.03% | -.--% | +36.42% | +75.13% | 919M | ||
| +0.48% | +1.19% | -9.81% | -11.89% | 69.92B | ||
| +1.94% | +3.29% | +3.73% | -28.71% | 7.19B | ||
| +0.21% | +0.52% | +0.21% | +0.10% | 3.62B | ||
| +3.01% | +7.04% | -5.26% | -9.76% | 3.26B | ||
| +1.87% | +6.35% | +26.99% | -8.32% | 2.31B | ||
| -1.06% | +1.18% | +46.42% | +10.52% | 1.26B | ||
| +0.74% | +17.93% | +78.75% | +53.13% | 1.21B | ||
| -0.13% | +0.95% | +1.79% | -40.85% | 1.05B | ||
| +0.27% | +1.08% | -20.55% | -35.90% | 1.04B | ||
| Average | +0.73% | +2.84% | +15.87% | +0.34% | 9.18B | |
| Weighted average by Cap. | +0.68% | +1.11% | -4.85% | -11.14% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 922M 786M 733M 678M 1.26B 79B 1.41B 8.78B 3.33B 36.81B 3.46B 3.38B 135B | 1.1B 940M 877M 811M 1.51B 94.47B 1.69B 10.5B 3.99B 44.02B 4.13B 4.05B 162B |
| Net income | -48.21M -41.11M -38.36M -35.46M -65.87M -4.13B -73.83M -459M -174M -1.93B -181M -177M -7.07B | 2.13M 1.82M 1.7M 1.57M 2.91M 183M 3.26M 20.3M 7.71M 85.13M 7.99M 7.83M 312M |
| Net Debt | 371M 316M 295M 273M 506M 31.78B 568M 3.53B 1.34B 14.81B 1.39B 1.36B 54.33B | 352M 300M 280M 259M 481M 30.17B 539M 3.35B 1.27B 14.06B 1.32B 1.29B 51.59B |
More financial data
* Estimated data
Employees
1,527
Sector
Pharmaceuticals
- Stock Market
- Equities
- PETQ Stock
Select your edition
All financial news and data tailored to specific country editions
